insulin resistance and tirzepatide for PCOS: Weight Management Tirzepatide and Obesity: A Narrative
Description
Understanding your GLP1R and GIPR pathways through biomarkers can help guide whether lifestyle alone or medical support is appropriate for your weight management goals
Recent estimates suggest that around 1.6 million adults used GLP-1 weight-loss drugs between early 2024 and early 2025, while broader data indicates up to 1.5 million people are currently taking them at any one time1
Understand the impact of gallbladder removal on hormone imbalances in women
Previous studies have shown that activation of the glucagon-like peptide-1 receptor (GLP-1R) leads to anti-inflammatory and anti-apoptotic effects
